Personal information

Other IDs

Scopus Author ID: 23059823900

Activities

Collapse all

Employment (1)

Universidad Mayor: Santiago, Región Metropolitana, CL

1998-05-01 to present | MD (Hemato-Oncologia)
Employment
Source: Self-asserted source
Marcelo Garrido

Funding (1)

Mechanisms Of Resistance To Immunotherapy Based On Checkpoint Inhibitors In Metastatic Gastric Cancers

2018-01-01 to present | Grant
Agencia Nacional de Investigación y Desarrollo (Santiago, CL)
URL: https://app.dimensions.ai/details/grant/grant.12969193
GRANT_NUMBER: 1180173
Source: Self-asserted source
Marcelo Garrido via DimensionsWizard

Works (50 of 61)

Items per page:
Page 1 of 2

First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial

Journal of Clinical Oncology
2024-06-10 | Journal article
DOI: 10.1200/JCO.23.01601
Contributors: Yelena Y. Janjigian; Jaffer A. Ajani; Markus Moehler; Lin Shen; Marcelo Garrido; Carlos Gallardo; Lucjan Wyrwicz; Kensei Yamaguchi; James M. Cleary; Elena Elimova et al.
Source: check_circle
Crossref

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

The Lancet Oncology
2023-12 | Journal article
DOI: 10.1016/s1470-2045(23)00469-2
Part of ISSN: 1470-2045
Contributors: Josep M Llovet; Masatoshi Kudo; Philippe Merle; Tim Meyer; Shukui Qin; Masafumi Ikeda; Ruocai Xu; Julien Edeline; Baek-Yeol Ryoo; Zhenggang Ren et al.
Source: Self-asserted source
Marcelo Garrido

Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649

Journal of Clinical Oncology
2023-12-10 | Journal article
DOI: 10.1200/JCO.23.00170
Contributors: Markus Moehler; Hong Xiao; Steven I. Blum; Elena Elimova; David Cella; Kohei Shitara; Jaffer A. Ajani; Yelena Y. Janjigian; Marcelo Garrido; Lin Shen et al.
Source: check_circle
Crossref

129O Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study

Annals of Oncology
2023-11 | Journal article
DOI: 10.1016/j.annonc.2023.10.265
Part of ISSN: 0923-7534
Contributors: D-Y. Oh; Y.Y. Janjigian; S-E. Al-Batran; Z.A. Wainberg; E. van Cutsem; D. Molena; K. Muro; W.J. Hyung; L.S. Wyrwicz; T. Omori et al.
Source: Self-asserted source
Marcelo Garrido

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

The Lancet Oncology
2023-11 | Journal article
DOI: 10.1016/s1470-2045(23)00515-6
Part of ISSN: 1470-2045
Contributors: Sun Young Rha; Do-Youn Oh; Patricio Yañez; Yuxian Bai; Min-Hee Ryu; Jeeyun Lee; Fernando Rivera; Gustavo Vasconcelos Alves; Marcelo Garrido; Kai-Keen Shiu et al.
Source: Self-asserted source
Marcelo Garrido

The Mechanistic Link Between Oral Health and Immune Profile in Gastric Cancer

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
2023-11 | Journal article
DOI: 10.1016/j.oooo.2023.07.032
Part of ISSN: 2212-4403
Contributors: MATÍAS MUÑOZ-MEDEL; MAURICIO P. PINTO; MAURICIO SÁEZ; ROCÍO ARTIGAS; VERÓNICA VILLALOBOS; MÓNICA CÁCERES; KARINA CERECEDA; FRANZ VILLARROEL-ESPINDOLA; ALEX ARREDONDO; GERARD ÀLVAREZ et al.
Source: Self-asserted source
Marcelo Garrido

1590P Real-world gastric cancer (GC) in Latin America (LATAM) and Europe (EU)

Annals of Oncology
2023-10 | Journal article
DOI: 10.1016/j.annonc.2023.09.1502
Part of ISSN: 0923-7534
Contributors: B. Freile; S. Derks; T. van Schooten; F. Carneiro; R. Barros; C. Caballero; C.V. Gauna Colas; A. Riquelme; G. Pizarro; M. Garrido et al.
Source: Self-asserted source
Marcelo Garrido

VP1-2023: Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 study

Annals of Oncology
2023-03 | Journal article
DOI: 10.1016/j.annonc.2023.01.006
Part of ISSN: 0923-7534
Contributors: S.Y. Rha; L.S. Wyrwicz; P.E.Y. Weber; Y. Bai; M.H. Ryu; J. Lee; F. Rivera; G.V. Alves; M. Garrido; K-K. Shiu et al.
Source: Self-asserted source
Marcelo Garrido

Data from Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6532410.v1
Contributors: Keun-Wook Lee; Eric Van Cutsem; Yung-Jue Bang; Charles S. Fuchs; Iveta Kudaba; Marcelo Garrido; Hyun Cheol Chung; Jeeyun Lee; Hugo R. Castro; Joseph Chao et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplementary Figure from Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22486896.v1
Contributors: Keun-Wook Lee; Eric Van Cutsem; Yung-Jue Bang; Charles S. Fuchs; Iveta Kudaba; Marcelo Garrido; Hyun Cheol Chung; Jeeyun Lee; Hugo R. Castro; Joseph Chao et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplementary Table from Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22486887.v1
Contributors: Keun-Wook Lee; Eric Van Cutsem; Yung-Jue Bang; Charles S. Fuchs; Iveta Kudaba; Marcelo Garrido; Hyun Cheol Chung; Jeeyun Lee; Hugo R. Castro; Joseph Chao et al.
Source: check_circle
Crossref
grade
Preferred source (of 7)‎

Abstract C018: Disparities in the access to non-small cell lung cancer´s target therapies in Chile

Cancer Epidemiology, Biomarkers & Prevention
2023-01-01 | Journal article
DOI: 10.1158/1538-7755.disp22-c018
Part of ISSN: 1538-7755
Contributors: Solange V. Rivas; Evelin González; Alejandro Blanco; Carolina Ibáñez; Alejandro Corvalán; Marcelo Garrido; Gareth Owen; Katherine Marcelain; Ricardo Armisén
Source: Self-asserted source
Marcelo Garrido

Proteogenomic analysis in an early onset diffuse gastric cancer patient revealed alterations in PIK3R1, TP53, SMAD4 and a potential role of the PI3K-AKT and EGFR pathways: a case report

Journal of Gastrointestinal Oncology
2022-08 | Journal article
DOI: 10.21037/jgo-21-780
Part of ISSN: 2078-6891
Part of ISSN: 2219-679X
Contributors: Miguel Cordova-Delgado; Mauricio P. Pinto; Gonzalo Pizarro; Elard Koch; Cristian Vargas; Mauricio Hernández; Guillermo Nourdin; Pablo Saldivia; Maria Paz Rodriguez Z.; Alejandro Berkovits et al.
Source: Self-asserted source
Marcelo Garrido

Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study

Clinical Cancer Research
2022-08-15 | Journal article | Author
DOI: 10.1158/1078-0432.ccr-22-0121
Part of ISSN: 1078-0432
Part of ISSN: 1557-3265
Contributors: Keun-Wook Lee; Eric Van Cutsem; Yung-Jue Bang; Charles S. Fuchs; Iveta Kudaba; Marcelo Garrido; Hyun Chung; Jeeyun Lee; Hugo R. Castro; Joseph Chao et al.
Source: Self-asserted source
Marcelo Garrido
grade
Preferred source (of 2)‎

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

Nature
2022-03-31 | Journal article
DOI: 10.1038/s41586-022-04508-4
Part of ISSN: 0028-0836
Part of ISSN: 1476-4687
Contributors: Kohei Shitara; Jaffer A Ajani; Markus Moehler; Marcelo Garrido; Carlos Gallardo; Lin Shen; Kensei Yamaguchi; Lucjan Wyrwicz; Tomasz Skoczylas; Arinilda Bragagnoli et al.
Source: Self-asserted source
Marcelo Garrido

Nivolumab (NIVO) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy, safety, and subgroup analyses from CheckMate 649.

Journal of Clinical Oncology
2022-02-01 | Journal article
DOI: 10.1200/jco.2022.40.4_suppl.240
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Contributors: Kohei Shitara; Yelena Y. Janjigian; Markus H. Moehler; Marcelo Garrido; Carlos Gallardo; Lin Shen; Kensei Yamaguchi; Lucjan Wyrwicz; Tomasz Skoczylas; Arinilda Silva Campos Bragagnoli et al.
Source: Self-asserted source
Marcelo Garrido

LBA7 Nivolumab (NIVO) plus chemotherapy (Chemo) or ipilimumab (IPI) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 study

Annals of Oncology
2021-09 | Journal article
DOI: 10.1016/j.annonc.2021.08.2131
Part of ISSN: 0923-7534
Contributors: Y.Y. Janjigian; J.A. Ajani; M. Moehler; M. Garrido; C. Gallardo; L. Shen; K. Yamaguchi; L. Wyrwicz; T. Skoczylas; A. Bragagnoli et al.
Source: Self-asserted source
Marcelo Garrido

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

The Lancet
2021-07 | Journal article
DOI: 10.1016/s0140-6736(21)00797-2
Part of ISSN: 0140-6736
Contributors: Yelena Y Janjigian; Kohei Shitara; Markus Moehler; Marcelo Garrido; Pamela Salman; Lin Shen; Lucjan Wyrwicz; Kensei Yamaguchi; Tomasz Skoczylas; Arinilda Campos Bragagnoli et al.
Source: Self-asserted source
Marcelo Garrido

Abstract 2792: Galectin 9 promotes invasion and angiogenesis in vitro and associates with an immune-suppressive microenvironment in gastric cancer patients

Cancer Research
2021-07-01 | Journal article
DOI: 10.1158/1538-7445.am2021-2792
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Contributors: Charlotte Nicole Hill; Maximiliano Arce Arata; Camille Cabrolier; Noymar Luque; Pamela Gonzalez; Gabriela Maita; Ana Maria Vega-Letter; Patricia Luz Crawford; Marcelo Garrido; Gareth I. Owen
Source: Self-asserted source
Marcelo Garrido

Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10

Clinical Cancer Research
2021-04-01 | Journal article
DOI: 10.1158/1078-0432.ccr-20-2980
Part of ISSN: 1078-0432
Part of ISSN: 1557-3265
Contributors: Zev A. Wainberg; Charles S. Fuchs; Josep Tabernero; Kohei Shitara; Kei Muro; Eric Van Cutsem; Yung-Jue Bang; Hyun Cheol Chung; Kensei Yamaguchi; Eniko Varga et al.
Source: Self-asserted source
Marcelo Garrido
grade
Preferred source (of 2)‎

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

Gastric Cancer
2021-03 | Journal article
DOI: 10.1007/s10120-020-01116-x
Part of ISSN: 1436-3291
Part of ISSN: 1436-3305
Contributors: Paula Jimenez-Fonseca; Alberto Carmona-Bayonas; Eva Martínez de Castro; Ana Custodio; Carles Pericay Pijaume; Raquel Hernandez; Gema Aguado; Natalia Castro Unanua; Juana María Cano; Flora López et al.
Source: Self-asserted source
Marcelo Garrido

The Reprimo-Like Gene Is an Epigenetic-Mediated Tumor Suppressor and a Candidate Biomarker for the Non-Invasive Detection of Gastric Cancer

International Journal of Molecular Sciences
2020-12 | Journal article | Author
DOI: 10.3390/ijms21249472
Contributors: Maria Alejandra Alarcon; Wilda Olivares; Miguel Cordova-Delgado; Matias Munoz-Medel; Tomas de Mayo; Gonzalo Carrasco-Aviño; Ignacio Wichmann; Natalia Landeros; Julio Amigo; Enrique Norero et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American Realities

JCO Global Oncology
2020-11 | Journal article
DOI: 10.1200/jgo.19.00410
Part of ISSN: 2687-8941
Contributors: Germán Calderillo; Matías Muñoz-Medel; Edelmira Carbajal; Miguel Córdova-Delgado; Doris Durán; Ignacio N. Retamal; Piga Fernández; Absalón Espinoza; Rodrigo Salas; María de la Paz Mastretta et al.
Source: Self-asserted source
Marcelo Garrido

Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover

Journal of Biological Chemistry
2020-10 | Journal article
DOI: 10.1074/jbc.ra120.014887
Part of ISSN: 0021-9258
Contributors: Katie Alexander; Carolina A. Serrano; Asmi Chakraborty; Marie Nearing; Leona N. Council; Arnoldo Riquelme; Marcelo Garrido; Susan L. Bellis; Lesley E. Smythies; Phillip D. Smith
Source: Self-asserted source
Marcelo Garrido

Reply

Liver Transplantation
2020-10 | Journal article
DOI: 10.1002/lt.25849
Contributors: Carlos Benítez; Martin Inzunza; Martin Dib; Marcelo Garrido; Jorge A. Martínez
Source: check_circle
Crossref

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer

JAMA Oncology
2020-10-01 | Journal article
DOI: 10.1001/jamaoncol.2020.3370
Part of ISSN: 2374-2437
Contributors: Kohei Shitara; Eric Van Cutsem; Yung-Jue Bang; Charles Fuchs; Lucjan Wyrwicz; Keun-Wook Lee; Iveta Kudaba; Marcelo Garrido; Hyun Cheol Chung; Jeeyun Lee et al.
Source: Self-asserted source
Marcelo Garrido

LBA6_PR Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study

Annals of Oncology
2020-09 | Journal article
DOI: 10.1016/j.annonc.2020.08.2296
Part of ISSN: 0923-7534
Contributors: M. Moehler; K. Shitara; M. Garrido; P. Salman; L. Shen; L. Wyrwicz; K. Yamaguchi; T. Skoczylas; A. Campos Bragagnoli; T. Liu et al.
Source: Self-asserted source
Marcelo Garrido

A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability

Cancers
2020-07 | Journal article | Author
DOI: 10.3390/cancers12071863
Contributors: Mauricio P. Pinto; Miguel Cordova-Delgado; Ignacio N. Retamal; Matías Muñoz-Medel; M. Loreto Bravo; Doris Durán; Francisco Villanueva; César Sanchez; Francisco Acevedo; Sebastián Mondaca et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Living Donor Liver Transplantation for Imatinib‐Resistant Gastrointestinal Stromal Tumor Liver Metastases: A New Therapeutic Option in Transplant Oncology

Liver Transplantation
2020-07 | Journal article
DOI: 10.1002/lt.25769
Contributors: Carlos Benítez; Martin Inzunza; Sergio Riveros; Violeta Rivas; Marcelo Garrido; Martin Dib; Francisco Barrera; Juan P. Arab; Javiera Torres; Luis I. Cortinez et al.
Source: check_circle
Crossref

Cohort Profile: The Maule Cohort (MAUCO)

International Journal of Epidemiology
2020-06-01 | Journal article
DOI: 10.1093/ije/dyaa003
Part of ISSN: 0300-5771
Part of ISSN: 1464-3685
Contributors: Catterina Ferreccio; Andrea Huidobro; Sandra Cortés; Claudia Bambs; Pablo Toro; Vanessa Van De Wyngard; Johanna Acevedo; Fabio Paredes; Pía Venegas; Hugo Verdejo et al.
Source: Self-asserted source
Marcelo Garrido

Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer

Thrombosis and Haemostasis
2019-11 | Journal article
DOI: 10.1055/s-0039-1694012
Part of ISSN: 0340-6245
Part of ISSN: 2567-689X
Contributors: Alberto Carmona-Bayonas; Paula Jimenez-Fonseca; Marcelo Garrido; Ana Custodio; Raquel Hernandez; Alejandra Lacalle; Juana María Cano; Gema Aguado; Eva Martínez de Castro; Felipe Alvarez Manceñido et al.
Source: Self-asserted source
Marcelo Garrido

Pembrolizumab with or without chemotherapy vs chemotherapy in patients with advanced G/GEJ cancer (GC) including outcomes according to Microsatellite Instability-High (MSI-H) status in KEYNOTE-062

Annals of Oncology
2019-10 | Journal article
DOI: 10.1093/annonc/mdz394.035
Part of ISSN: 0923-7534
Contributors: K. Shitara; E. Van Cutsem; Y.-J. Bang; C.S. Fuchs; L. Wyrwicz; K.W. Lee; I. Kudaba; M. Garrido; H. Cheol Chung; H.R. Castro et al.
Source: Self-asserted source
Marcelo Garrido

Identification of c.1531C>T Pathogenic Variant in the CDH1 Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer

International Journal of Molecular Sciences
2019-10-09 | Journal article
DOI: 10.3390/ijms20204980
Contributors: Enrique Norero; M. Alejandra Alarcon; Christopher Hakkaart; Tomas de Mayo; Cecilia Mellado; Marcelo Garrido; Gloria Aguayo; Marcela Lagos; Javiera Torres; Alfonso Calvo et al.
Source: check_circle
Crossref

High Proportion of Potential Candidates for Immunotherapy in a Chilean Cohort of Gastric Cancer Patients: Results of the FORCE1 Study

Cancers
2019-08-30 | Journal article
DOI: 10.3390/cancers11091275
Part of ISSN: 2072-6694
Contributors: Miguel Cordova-Delgado; Mauricio P. Pinto; Ignacio N. Retamal; Matías Muñoz-Medel; María Loreto Bravo; María F. Fernández; Betzabé Cisternas; Sebastián Mondaca; César Sanchez; Hector Galindo et al.
Source: Self-asserted source
Marcelo Garrido

Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study

Gastric Cancer
2019-07 | Journal article
DOI: 10.1007/s10120-018-00909-5
Part of ISSN: 1436-3291
Part of ISSN: 1436-3305
Contributors: Yung-Jue Bang; Yoon-Koo Kang; Daniel V. Catenacci; Kei Muro; Charles S. Fuchs; Ravit Geva; Hiroki Hara; Talia Golan; Marcelo Garrido; Shadia I. Jalal et al.
Source: Self-asserted source
Marcelo Garrido

Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study.

Journal of Clinical Oncology
2019-06-20 | Journal article
DOI: 10.1200/jco.2019.37.18_suppl.lba4007
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Contributors: Josep Tabernero; Eric Van Cutsem; Yung-Jue Bang; Charles S. Fuchs; Lucjan Wyrwicz; Keun Wook Lee; Iveta Kudaba; Marcelo Garrido; Hyun Cheol Chung; Hugo Raul Castro Salguero et al.
Source: Self-asserted source
Marcelo Garrido

Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective

Hormones and Cancer
2019-02 | Journal article
DOI: 10.1007/s12672-018-0354-5
Part of ISSN: 1868-8497
Part of ISSN: 1868-8500
Contributors: Mauricio P. Pinto; Matías Muñoz Medel; Diego Carrillo; Ignacio N. Retamal; M. Loreto Bravo; Yasna Valenzuela; Bruno Nervi; César Sánchez; Héctor Galindo; Carolina Ibañez et al.
Source: Self-asserted source
Marcelo Garrido

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial

Annals of Oncology
2019-02 | Journal article
DOI: 10.1093/annonc/mdy545
Part of ISSN: 0923-7534
Contributors: R.S. Herbst; P. Baas; J.L. Perez-Gracia; E. Felip; D.-W. Kim; J.-Y. Han; J.R. Molina; J.-H. Kim; C. Dubos Arvis; M.-J. Ahn et al.
Source: Self-asserted source
Marcelo Garrido

Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer Patients

Asian Pacific Journal of Cancer Prevention
2019-01-01 | Journal article
DOI: 10.31557/apjcp.2019.20.1.1
Part of ISSN: 2476-762X
Contributors: Roger Gejman; Sergio Gonzalez; Matias Munoz Medel; Bruno Nervi; Cesar Sanchez; Carolina Ibáñez; Jose Peña; Jorge Madrid; Juan Briones; Patricia Perez et al.
Source: Self-asserted source
Marcelo Garrido

Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry

European Journal of Surgical Oncology
2018-08 | Journal article
DOI: 10.1016/j.ejso.2018.03.019
Part of ISSN: 0748-7983
Contributors: Alberto Carmona-Bayonas; Paula Jiménez-Fonseca; Isabel Echavarria; Manuel Sánchez Cánovas; Gema Aguado; Javier Gallego; Ana Custodio; Raquel Hernández; Antonio Viudez; Juana María Cano et al.
Source: Self-asserted source
Marcelo Garrido

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer

JAMA Oncology
2018-05-10 | Journal article
DOI: 10.1001/jamaoncol.2018.0013
Part of ISSN: 2374-2437
Contributors: Charles S. Fuchs; Toshihiko Doi; Raymond W. Jang; Kei Muro; Taroh Satoh; Manuela Machado; Weijing Sun; Shadia I. Jalal; Manish A. Shah; Jean-Phillipe Metges et al.
Source: Self-asserted source
Marcelo Garrido

KEYNOTE-059 Update: Efficacy and safety of pembrolizumab alone or in combination with chemotherapy in patients with advanced gastric or gastroesophageal (G/GEJ) cancer

Annals of Oncology
2017-09 | Journal article
DOI: 10.1093/annonc/mdx440.020
Part of ISSN: 0923-7534
Contributors: Z.A. Wainberg; S. Jalal; K. Muro; H.H. Yoon; M. Garrido; T. Golan; T. Doi; D.V. Catenacci; R. Geva; G. Ku et al.
Source: Self-asserted source
Marcelo Garrido
grade
Preferred source (of 2)‎

Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry

British Journal of Cancer
2017-09 | Journal article
DOI: 10.1038/bjc.2017.245
Part of ISSN: 0007-0920
Part of ISSN: 1532-1827
Contributors: Paula Jiménez Fonseca; on behalf of the AGAMENON study group; Alberto Carmona-Bayonas; Raquel Hernández; Ana Custodio; Juana Maria Cano; Alejandra Lacalle; Isabel Echavarria; Ismael Macias; Monserrat Mangas et al.
Source: Self-asserted source
Marcelo Garrido
grade
Preferred source (of 2)‎

Angiogenesis inhibitors in early development for gastric cancer

Expert Opinion on Investigational Drugs
2017-09-02 | Journal article
DOI: 10.1080/13543784.2017.1361926
Part of ISSN: 1354-3784
Part of ISSN: 1744-7658
Contributors: Mauricio P. Pinto; Gareth I. Owen; Ignacio Retamal; Marcelo Garrido
Source: Self-asserted source
Marcelo Garrido
grade
Preferred source (of 2)‎

KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer

Annals of Oncology
2017-06 | Journal article
DOI: 10.1093/annonc/mdx302.008
Part of ISSN: 0923-7534
Contributors: V. Catenacci Daniel; Zev Wainberg; S. Fuchs Charles; Marcelo Garrido; Yung-Jue Bang; Kei Muro; Mary Savage; Jiangdian Wang; Minori Koshiji; P. Dalal Rita et al.
Source: Self-asserted source
Marcelo Garrido

Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer

Gastric Cancer
2017-05 | Journal article
DOI: 10.1007/s10120-016-0639-8
Part of ISSN: 1436-3291
Part of ISSN: 1436-3305
Contributors: Paula Jiménez-Fonseca; Alberto Carmona-Bayonas; Maria Luisa Sánchez Lorenzo; Javier Gallego Plazas; Ana Custodio; Raquel Hernández; Marcelo Garrido; Teresa García; Isabel Echavarría; Juana María Cano et al.
Source: Self-asserted source
Marcelo Garrido

Factors associated with better overall survival (OS) in patients with previously treated, PD-L1–expressing, advanced NSCLC: Multivariate analysis of KEYNOTE-010.

Journal of Clinical Oncology
2017-05-20 | Journal article
DOI: 10.1200/jco.2017.35.15_suppl.9090
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Contributors: Roy S. Herbst; Paul Baas; Dong-Wan Kim; Enriqueta Felip; Jose Luis Perez-Gracia; Ji-Youn Han; Julian R. Molina; Joo-Hang Kim; Catherine Dubos Arvis; Myung-Ju Ahn et al.
Source: Self-asserted source
Marcelo Garrido

KEYNOTE-059 cohort 1: Efficacy and safety of pembrolizumab (pembro) monotherapy in patients with previously treated advanced gastric cancer.

Journal of Clinical Oncology
2017-05-20 | Journal article
DOI: 10.1200/jco.2017.35.15_suppl.4003
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Contributors: Charles S. Fuchs; Toshihiko Doi; Raymond Woo-Jun Jang; Kei Muro; Taroh Satoh; Manuela Machado; Weijing Sun; Shadia Ibrahim Jalal; Manish A. Shah; Jean-Philippe Metges et al.
Source: Self-asserted source
Marcelo Garrido

Two randomized, placebo-controlled phase 3 studies of ruxolitinib (Rux) + capecitabine (C) in patients (pts) with advanced/metastatic pancreatic cancer (mPC) after failure/intolerance of first-line chemotherapy: JANUS 1 (J1) and JANUS 2 (J2).

Journal of Clinical Oncology
2017-02-01 | Journal article
DOI: 10.1200/jco.2017.35.4_suppl.343
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Contributors: Herbert Hurwitz; Eric Van Cutsem; Johanna C. Bendell; Manuel Hidalgo; Chung-Pin Li; Marcelo Garrido; Teresa Mercade Macarulla; Vaibhav Sahai; Ashwin Reddy Sama; Edward Greeno et al.
Source: Self-asserted source
Marcelo Garrido

On the Effect of Triplet or Doublet Chemotherapy in Advanced Gastric Cancer: Results From a National Cancer Registry

Journal of the National Comprehensive Cancer Network
2016-11 | Journal article
DOI: 10.6004/jnccn.2016.0148
Part of ISSN: 1540-1405
Part of ISSN: 1540-1413
Contributors: Alberto Carmona-Bayonas; Paula Jiménez-Fonseca; Maria Luisa Sánchez Lorenzo; Avinash Ramchandani; Elena Asensio Martínez; Ana Custodio; Marcelo Garrido; Isabel Echavarría; Juana María Cano; Jose Enrique Lorenzo Barreto et al.
Source: Self-asserted source
Marcelo Garrido
Items per page:
Page 1 of 2
How many people are using ORCID?